Will oral rivaroxaban improve clinically relevant outcomes and thromboprophylaxis management in the orthopedic patient?

J Thromb Haemost. 2009 Dec;7(12):2149-50. doi: 10.1111/j.1538-7836.2009.03618.x. Epub 2009 Sep 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Morpholines / administration & dosage*
  • Orthopedics*
  • Postoperative Complications / prevention & control
  • Premedication
  • Rivaroxaban
  • Thiophenes / administration & dosage*
  • Thrombosis / prevention & control*
  • Treatment Outcome

Substances

  • Morpholines
  • Thiophenes
  • Rivaroxaban